| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9876 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8432 |
| P-glycoprotein Substrate | Non-substrate | 0.8063 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8269 |
| Non-inhibitor | 0.9466 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8231 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8165 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8204 |
| CYP450 2D6 Substrate | Non-substrate | 0.8148 |
| CYP450 3A4 Substrate | Non-substrate | 0.7207 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9358 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.8267 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9529 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7960 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9115 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.8335 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9672 |
| Non-inhibitor | 0.8191 |
| AMES Toxicity | Non AMES toxic | 0.9711 |
| Carcinogens | Non-carcinogens | 0.5950 |
| Fish Toxicity | High FHMT | 0.9930 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9999 |
| Honey Bee Toxicity | High HBT | 0.6482 |
| Biodegradation | Not ready biodegradable | 0.9751 |
| Acute Oral Toxicity | III | 0.5283 |
| Carcinogenicity (Three-class) | Non-required | 0.5239 |